WallStSmart

Churchill Capital Corp XI (CCXI)vsLegato Merger Corp. IV (LEGO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

LEGO leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

LEGO

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

LEGO0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$677.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

LEGO4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$340.95M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : LEGO

LEGO has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : LEGO

The primary concerns for LEGO are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

LEGO is growing revenue faster at 0.0% — sustainability is the question.

LEGO generates stronger free cash flow (-247,240), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Legato Merger Corp. IV

FINANCIAL SERVICES · SHELL COMPANIES · USA

Legato Merger Corp. IV is a special purpose acquisition company (SPAC) dedicated to identifying and merging with high-growth companies within the technology and consumer sectors. Focused on creating value through strategic partnerships, Legato leverages its management team's extensive expertise in corporate development and investment strategies to enhance operational efficiency and drive long-term shareholder growth. This positions the firm as an attractive opportunity for institutional investors aiming to access promising ventures in an evolving marketplace.

Want to dig deeper into these stocks?